GPCR Therapeutics
@gpcr.co.kr
GPCR Therapeutics, Inc. is a venture-backed, clinical stage international biopharmaceutical company with an innovative approach to developing therapeutics built on its proprietary GPCR data. The company’s proprietary data driven approach has identified over 1000 GPCR pairs upon which drug screening campaigns can be pursued. Identification of the best GPCR pair to target for specific disease indications and patient subpopulations creates a personalized approach to combination therapy. By targeting the unique pharmacology of GPCR pairs, we aim to develop life changing treatments for cancer and other diseases.
GPCR Therapeutics's Company Logos
GPCR Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1A73E8
Royal Blue
26, 115, 232
214, 82, 51
89, 50, 0, 9
#999999
Dusty Gray
153, 153, 153
0, 0, 60
0, 0, 0, 40
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
About GPCR Therapeutics
GPCR Therapeutics, Inc. Our mission is to utilize the novel science of GPCR heteromers to create innovative pharmaceuticals that target cancer cells. Through our cutting-edge research, we are committed to bringing hope and optimism to patients and their families.
At GPCR Therapeutics, we believe in working hard and being passionate about what we do. Our vision is to produce pharmaceuticals that address unmet medical needs for the treatment of cancer. We are driven by a strong desire to make a difference and improve the lives of those affected by cancer.
With a dedicated team of experts and a focus on GPCR and their heteromers, we have developed a unique drug discovery platform. Our CXCR4 Heteromer Interactome and the overall flow of target selection ensure that our products are based on robust scientific research. Join us in our mission to revolutionize cancer treatment and make a lasting impact on the lives of patients worldwide
